Thermo Fisher Scientific has officially opened its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, CA. 1 The ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson ...

When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Keeping that in mind, LogiPharma Europe wanted to find ways to remedy that challenge, and welcomed a panel discussion on “Future-Proofing for Complex Novel Modalities: How Can You Deliver Personalized ...

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Rachel Thorpe, executive director at ...

Will Robinson, program director, LogiPharma, reveals why the conference will be moved to Vienna moving forward.

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & ...

The new firm—with 13 manufacturing facilities spanning France, Sweden, and Spain—will support the pharma supply chain through ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson ...

Growth through acquisition has been an attractive option for many organizations in the pharma cold chain. One recent example ...

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and ...

Will Robinson, program director, LogiPharma, explains how artificial intelligence and sustainability are driving a clear shift in priorities across the pharmaceutical supply chain. PC: When comparing ...